1. Ota K, Nakajima T, Ishihara S, Oyama S, Wakabayashi K, Nishi M (1994) Treatment of recurrent gastric cancer. Gan To Kagaku Ryoho (Jpn J Cancer Chemother) 21:1806–1812
2. Koike H, Konishi T, Mafune K, Hirata T, Miyama T, Hiraishi M, Idezuki Y (1989) Effect of sequential MTX/5-FU therapy for a case of disseminated intravascular coagulation syndrome associated with recurrence of gastric cancer: a case report. Nippon Geka Gakkai Zasshi (J Jpn Surg Soc) 90:1117–1121
3. Speyer JL (1985) The rationale behind intraperitoneal chemotherapy in gastrointestinal malignancies. Semin Oncol 12 (Suppl 4):23–28
4. Sugarbaker PH, Cunliffe WJ, Belliveau J, de Bruiji EA, Graves T, Mullins RE, Schlag P (1989) Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol 16 (Suppl 6):83–97
5. Zimm S, Cleary SM, Lucas WE, Weiss RJ, Markman M, Andrews PA, Schiefer MA, Kim S, Horton C, Howell SB (1998) Phase I/pharmacokinetic study of intraperitoneal cisplatin and etoposide. Cancer Res 47:1712–1716